Efficacy of a hybrid online training for panic symptoms and agoraphobia: study protocol for a randomized controlled trial

Table 2 Overview of instruments per time of assessment

Assessments	Screening	T0	T1	T2	T3
Sociodemographic data	x	-	-	-	-
Suicidality (Item 9, BDI-II)	x	-	-	-	-
Diagnosis (SCID-I, sections for anxiety disorders and current depressive episode)	-	x	-	-
Panic and agoraphobia severity, self-rating (PAS)	x	x	x	x	x
Panic and agoraphobia severity, observer-rating (HAM-A)	-	x	x	-	-
Agoraphobic cognitions (ACQ)	-	x	x	x	x
Body sensations (BSQ)	-	x	x	x	x
Agoraphobic avoidance (MI)	-	x	x	x	x
Depressive symptoms (CES-D)	-	x	x	x	x
Quality of life (EQ-5D, SF-12)	-	x	x	x	x
Economic evaluations (TiC-P)	-	x	-	-	x
Negative effects of online health trainings	-	-	(x)	(x)	(x)
Attitudes towards seeking psychological help	-	-	(x)	-	-
User satisfactory	-	-	(x)	-	-
Technology acceptance of smartphone app	-	-	(x)	-	-
Usability of smartphone app (SUS)	-	-	(x)	-	-

T0 = Baseline, T1 = 8 weeks, T2 = 3 months, T4 = 6 months.
Assessments: x = intervention and control group, (x) = intervention group only.
ACQ, Agoraphobic cognitions questionnaire; BDI-II, Beck Depression Inventory II; BSQ, Body sensations questionnaire; CES-D, Center for epidemiological studies depression scale; EQ-5D, EuroQol; HAM-A, Hamilton anxiety scale; MI, Mobility inventory; PAS, Panic and agoraphobia scale; SCID-I, Structured clinical interview for DSM-IV Axis I Disorders; SF-12, Short form 12; SUS, System Usability Scale; TiC-P, Trimbos and the Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry.

ISSN: 1745-6215